Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients
Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients
With the extension of the average life expectancy, the incidence of cardiovascular diseases
 is also rising. Stroke in Taiwan has been the leading cause of morbidity and mortality, but
 also in countries around the world), stroke and the impact of socio-economic and health
 spending are large how to reduce the degree of disability after stroke is an important issue
 in medicine. For a long time, the resident will fill the clinical pathway form before the
 stroke inpatients were discharged. We also analyzed the data of clinical pathway every three
 months.

 According to the current data of stroke clinical pathway included demographic data, length of
 hospitalization days, complications, functional independent measure, Brunnstrom motor
 recovery stage, mini-mental state examination, geriatric depression scale, blood pressure
 data, and post-stroke checklist for a retrospective analysis to provide more complete and
 more comprehensive information on follow-up care for stroke patients and effective use of
 medical resources, to improve the quality of future medical care and quality of life for
 stroke patients.
Inclusion Criteria:

 1. Ischemic and hemorrhagic stroke patients

 2. MRI confirmed the diagnosis of stroke

 3. Within three months of onset of unilateral limb hemiplegia in patients

 Exclusion Criteria:

 1. Initial tracheostomy impantation and hospital stay is less than 5 days

 2. Combined with other neurological diseases, such as epilepsy, multiple neuropathy,
 Meniere's disease, vestibular neuritis, Parkinson's disease, dementia or cerebellar
 atrophy, etc.

 3. Significant lesions of the lower limb joints, including joint contractures, lower limb
 fractures, joint replacement or long-term pain in patients with osteoarthritis

 4. Unstable signs of life (if not through the tilt bed test) or severe cardiopulmonary
 disease

 5. Those who can not cooperate with the study or who have not signed the inform consent